化合物 Avatrombopag maleate T68888
品牌 | 厂商性质 | 产地 | 货期 |
---|---|---|---|
TargetMol | 生产商 | 美国 | 现货 |
性能特点
生化试剂,可用于动物细胞实验
规格 | CAS号 | 价格 | 操作 |
---|---|---|---|
25 mg | 677007-74-8 | ¥10,600.00 | 询底价 |
50 mg | 677007-74-8 | ¥13,800.00 | 询底价 |
100 mg | 677007-74-8 | ¥17,500.00 | 询底价 |
Product Introduction
Bioactivity
英文名: Avatrombopag maleate
描述: Avatrombopag, also known as AKR-501, YM477, AS 1670542 or E5501, is a novel orally-active thrombopoietin (TPO) receptor agonist. AKR-501 specifically targeted the TPO receptor and stimulated megakaryocytopoiesis throughout the development and maturation of megakaryocytes just as rhTPO did. AKR-501 may be useful in the treatment of patients with thrombocytopenia. Avatrombopag was first approved in 2018.
存储条件: Powder: -20°C for 3 years | In solvent: -80°C for 1 year
关键字: AS 1670542 | AKR 501 | YM 477 | E-5501 | Avatrombopag | Avatrombopag Maleate | AS-1670542 | E5501 | E 5501 | Avatrombopag maleate. | AS1670542 | YM477 | YM-477 | AKR-501
化合物 Avatrombopag maleate T68888信息由TargetMol中国为您提供,如您想了解更多关于化合物 Avatrombopag maleate T68888报价、型号、参数等信息,欢迎来电或留言咨询。
注:该产品未在中华人民共和国食品药品监督管理部门申请医疗器械注册和备案,不可用于临床诊断或治疗等相关用途